| # | Side effect | Count |
|---|---|---|
| 0 | PRODUCT DOSE OMISSION ISSUE | 76 |
| 1 | FATIGUE | 35 |
| 2 | DIZZINESS | 25 |
| 3 | DYSPNOEA | 24 |
| 4 | HEADACHE | 22 |
| 5 | PRODUCT USE ISSUE | 17 |
| 6 | NAUSEA | 14 |
| 7 | COVID-19 | 13 |
| 8 | DRUG INEFFECTIVE | 13 |
| 9 | PAIN | 12 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | SI QIII TIII PATTERN | 1 | 0.3333 |
| 1 | LUNG INDURATION | 1 | 0.0556 |
| 2 | MYOPIC CHORIORETINAL DEGENERATION | 1 | 0.0357 |
| 3 | PAPILLARY RENAL CELL CARCINOMA | 1 | 0.0074 |
| 4 | BIRTH MARK | 1 | 0.0048 |
| 5 | GENITAL HERPES SIMPLEX | 1 | 0.0047 |
| 6 | DYSCALCULIA | 1 | 0.0040 |
| 7 | CERVIX CARCINOMA STAGE 0 | 1 | 0.0035 |
| 8 | RELAPSING MULTIPLE SCLEROSIS | 1 | 0.0033 |
| 9 | NEUROMUSCULAR TOXICITY | 1 | 0.0028 |